Evaluation of the Efficacy of Ginger, Arabic Gum, and Boswellia in Acute and Chronic Renal Failure
Overview
Affiliations
This study was conducted to evaluate the effects of Zingiber officinale Roscoe (Ginger), Arabic gum (AG), and Boswellia on both acute and chronic renal failure (CRF) and the mechanisms underlying their effects. Acute renal failure was induced by 30 min ischemia followed by 24 h reperfusion, while CRF was induced by adenine feeding for 8 weeks. Prophylactic oral administration of ginger, AG, Boswellia, or vehicle (in control groups) was started 3 days before and along with adenine feeding in different groups or 7 days before ischemia-reperfusion. Ginger and AG showed renoprotective effects in both models of renal failure. These protective effects may be attributed at least in part to their anti-inflammatory properties as evident by attenuating serum C-reactive protein levels and antioxidant effects as evident by attenuating lipid peroxidation marker, malondialdehyde levels, and increasing renal superoxide dismutase activity. Ginger was more potent than AG in both models of renal failure. However, Boswellia showed only partial protective effect against both acute renal failure and CRF and it had no antioxidant effects. Finally, we can say that ginger and AG could be beneficial adjuvant therapy in patients with acute renal failure and CRF to prevent disease progression and delay the need for renal replacement therapy.
Therapeutic Potential of Gum Arabic () in Chronic Kidney Disease Management: A Narrative Review.
Alobaidi S J Clin Med. 2024; 13(19).
PMID: 39407837 PMC: 11477033. DOI: 10.3390/jcm13195778.
Effects of frankincense on experimentally induced renal stones in rats.
Al-Marhoon M, Al-Harrasi A, Siddiqui K, Ashique M, Ali H, Ali B BJUI Compass. 2023; 4(4):437-445.
PMID: 37334022 PMC: 10268574. DOI: 10.1002/bco2.227.
Gouda E, Babiker F Sci Rep. 2022; 12(1):17235.
PMID: 36241904 PMC: 9568585. DOI: 10.1038/s41598-022-22097-0.
Ahmed N, El-Rayes S, Khalil W, Abdeen A, Abdelkader A, Youssef M Toxins (Basel). 2022; 14(9).
PMID: 36136543 PMC: 9500620. DOI: 10.3390/toxins14090605.
Huang K, Chen Y, Liang K, Xu X, Jiang J, Liu M Evid Based Complement Alternat Med. 2022; 2022:6627104.
PMID: 35069765 PMC: 8776457. DOI: 10.1155/2022/6627104.